Watson Pharmaceuticals (WPI) seeks FDA approval to market generic Beyaz after facing a lawsuit...

|By:, SA News Editor

Watson Pharmaceuticals (WPI) seeks FDA approval to market generic Beyaz after facing a lawsuit from Bayer (BAYRY.PK) challenging a patent on the drug. The firm says it believes that it may be a "first applicant" to file an ANDA for the generic version of Beyaz and should be entitled to 180 days of generic market exclusivity.